Phase 1/2a Study of Belantamab Mafodotin in Relapsed or Refractory AL Amyloidosis
Clinical trial NCT05145816 · RECRUITING
Trial details
- NCT number
- NCT05145816
- Sponsor
- University of Texas Southwestern Medical Center
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-15
- Primary completion
- 2027-03-01
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.